Table 8.
Comparative results of ESBL producers against quinolone-resistant E. coli isolates.
| ESBL Producer Isolate | Quinolone-Resistant Isolate | ||||||
|---|---|---|---|---|---|---|---|
| R | S | p-Value | R | S | p-Value | ||
| CHL | 36.2(109) | 63.8(192) | 0.080 | CHL | 70.5(122) | 11.1(32) | 0.000 |
| GEN | 33.6(101) | 64.4(200) | 0.360 | GEN | 60.1(104) | 15.3(44) | 0.000 |
| TET | 70.1(211) | 29.9(90) | 0.007 | TET | 92.5(160) | 49.7(143) | 0.000 |
| DOX | 52.5(158) | 47.5(143) | 0.160 | DOX | 80.9(140) | 31.6(91) | 0.000 |
| SXT | 55.5(167) | 44.5(134) | 0.261 | SXT | 82.7(143) | 36.1(104) | 0.000 |
Key: CIP, ciprofloxacin; CHL, chloramphenicol; NAL, nalidixic acid; GEN, gentamycin; AMP, ampicillin; TET, tetracycline; DOX, doxycycline; SXT, trimethoprim/sulfamethoxazole; CTX, cefotaxime; MEM, meropenem.